Intuitive Surgical, Fosun Pair Up For Lung Cancer JV
Intuitive Surgical is setting up a China-based joint venture with its distribution partner Fosun Pharma that will develop robotic-assisted, catheter-based devices for diagnosing and treating lung cancer.
You may also be interested in...
The road to China's health-care market, once seen to be paved with gold by many medtech companies, is presenting more obstacles than before as a result of increased local competition and challenging policies. Multinationals and start-ups attending the recent China Healthcare Investment Conference discussed ways in which the medtech industry could continue to capitalize on this market's potential.
From "smart" snake-like catheters to miniscule-sized devices, a new generation of surgical robots, developed at world-renowned research institutions, aims to explore a new frontier by allowing doctors to target inaccessible areas within the body, and treat conditions with greater precision and better patient outcomes. With the surgical robotics market projected to surpass $10bn by 2021, a growing number of companies are hoping to capture their share in this trending space.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.